Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Year: 2008
Type: review
DOI: 10.1038/ncprheum0797
Institutions: BioZyme (United States), Teva Pharmaceuticals (Israel)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2141436693
